One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Accesshttps://doi.org/10.1182/blood.v118.21.3959.3959
Copy DOI Journal: Blood |  Publication Date: Nov 18, 2011 |
 Citations: 1 |
Affiliation: The University of Texas MD Anderson Cancer Center, University of North Carolina at Chapel Hill, Fred Hutch Cancer Center, Cornell University, Emory University, Fox Chase Cancer Center, Saint Vincent Health System, Moffitt Cancer Center, University of Arkansas for Medical Sciences, Janssen (Belgium), Ortho Clinical Diagnostics (United States), Bon Secours Health SystemLong-Term Safety in a Phase 1 Study of Siltuximab (CNTO 328), an Anti-Interleukin-6 Monoclonal Antibody, in Patients with B-Cell Non-Hodgkin's Lymphoma, Multiple Myeloma, or Castleman's Disease,
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
